Previous close | 5,146.00 |
Open | 5,160.00 |
Bid | 5,207.00 x 200 |
Ask | 5,210.00 x 34100 |
Day's range | 5,152.00 - 5,230.00 |
52-week range | 2,637.00 - 5,379.00 |
Volume | |
Avg. volume | 1,375,194 |
Market cap | 59.297B |
Beta (5Y monthly) | 1.06 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 28 Nov 2017 |
1y target est | N/A |
Let us look at five drug, generic companies, PRGO, IOVA, VTRS, TEVA and ACAD, which are gearing up for their earnings release this week.
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But one can do...
Evaluate the expected performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.